Personal information

No personal information available

Activities

Collapse all

Works (10)

Model‐Based Investigation of Inadequate Efficacy of Tesnatilimab, an Anti–Natural Killer Group 2 Member D Monoclonal Antibody, in Moderately to Severely Active Crohn Disease

The Journal of Clinical Pharmacology
2023-08 | Journal article
DOI: 10.1002/jcph.2252
Contributors: Jie Zhou; Yan Xu; Yang Chen; Jie Shao; Yaming Su; Zhenhua Xu; Honghui Zhou; Christopher O'Brien
Source: check_circle
Crossref

Population Pharmacokinetic Modeling of Lucitanib in Patients with Advanced Cancer

European Journal of Drug Metabolism and Pharmacokinetics
2022-09 | Journal article
DOI: 10.1007/s13318-022-00773-w
Contributors: Mingxiang Liao; Jie Zhou; Kenton Wride; Denise Lepley; Terri Cameron; Mark Sale; Jim Xiao
Source: check_circle
Crossref

Population pharmacokinetics-based recommendations for a single delayed or missed dose of nusinersen

Neuromuscular Disorders
2021-04 | Journal article
DOI: 10.1016/j.nmd.2021.02.014
Part of ISSN: 0960-8966
Source: Self-asserted source
JIE ZHOU

A population pharmacodynamic Markov mixed‐effects model for determining remimazolam‐induced sedation when co‐administered with fentanyl in procedural sedation

Clinical and Translational Science
2021-04-09 | Journal article
DOI: 10.1111/cts.13023
Part of ISSN: 1752-8054
Part of ISSN: 1752-8062
Source: Self-asserted source
JIE ZHOU

Population Pharmacokinetics of Remimazolam in Procedural Sedation With Nonhomogeneously Mixed Arterial and Venous Concentrations

Clinical and Translational Science
2021-01 | Journal article
DOI: 10.1111/cts.12875
Part of ISSN: 1752-8054
Part of ISSN: 1752-8062
Source: Self-asserted source
JIE ZHOU

Population pharmacokinetic/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects

Journal of Clinical Anesthesia
2020-11 | Journal article
DOI: 10.1016/j.jclinane.2020.109899
Part of ISSN: 0952-8180
Source: Self-asserted source
JIE ZHOU

The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID‐19

Clinical Pharmacology & Therapeutics
2020-10 | Journal article
DOI: 10.1002/cpt.1889
Contributors: Virginia D. Schmith; Jie (Jessie) Zhou; Lauren R.L. Lohmer
Source: check_circle
Crossref

The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19

[]
2020-04-26 | Preprint
DOI: 10.1101/2020.04.21.20073262
Source: Self-asserted source
JIE ZHOU

Mechanisms of Antioxidant Induction with High-Dose N-Acetylcysteine in Childhood Cerebral Adrenoleukodystrophy

CNS Drugs
2015-12 | Journal article
DOI: 10.1007/s40263-015-0300-9
Part of ISSN: 1172-7047
Part of ISSN: 1179-1934
Source: Self-asserted source
JIE ZHOU

Intravenous Administration of Stable-Labeled N-Acetylcysteine Demonstrates an Indirect Mechanism for Boosting Glutathione and Improving Redox Status

Journal of Pharmaceutical Sciences
2015-08 | Journal article
DOI: 10.1002/jps.24482
Part of ISSN: 0022-3549
Source: Self-asserted source
JIE ZHOU
How many people are using ORCID?